|
Michael MontagueSubstack: The Emergent Scientist Dr. Montague is co-appointed at the Archimedes Network as its Director and Co-Counder. and at the Quantum Biology Institute as its CTO and Head of Microbiology. Dr. Montague's research at the Archimedes Network is focused upon threat modeling of biotechnology, artificial intelligence, information hazard management, and weapon theory, with an emphasis upon deliberate use. Dr. Montague's research at the Quantum Biology Institute is focused upon the characterization of magnetosensitivity in model organisms using hypomagnetic chambers and modern multi-omics approaches. Prior to being at the Archimedes Network, Michael was a Senior Scholar at the Center for Health Security at Hopkins,and a Research Associate at the Future for Humanity Institute. Michael Montague received his bachelor degree in Biochemistry from the University of Dallas in 1997, and his PhD in Microbiology from the University of North Carolina at Chapel Hill. His 2005 dissertation title was "Functional Phylogeny of Protein Families". He then spent 8 years working at the J. Craig Venter Institute in Rockville MD where he was involved in research that was foundational to the modern genetic engineering methodologies that are now collectively refereed to as "Synthetic Biology". |
Publications (31) |
Quantum Biology (3) |
|
(2025) "Scale Shifting: Quantum Biology, Quantum Omics, & a Quantum Biotech Future" (2024) "Quantum Biology Risks: A Threat Model to Inform Research and Development Funding." |
Microbiology, Bioinformatics, and Molecular Biology (4) |
(2009) "The Evolution of RecD Outside of the RecBCD Complex." (2000) "Gene content phylogeny of herpesviruses." (2000) "Hrs interacts with SNAP-25 and regulates Ca2+-dependent exocytosis." |